Allele-Specific RNA Silencing of Mutant Ataxin-3 Mediates Neuroprotection in a Rat Model of Machado-Joseph Disease-Reference-Cited by-同舟云学术

Allele-Specific RNA Silencing of Mutant Ataxin-3 Mediates Neuroprotection in a Rat Model of Machado-Joseph Disease

Published:2008-10-08 Issue:10 Volume:3 Page:e3341
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Alves Sandro,Nascimento-Ferreira Isabel,Auregan Gwennaëlle,Hassig Raymonde,Dufour Noëlle,Brouillet Emmanuel,Pedroso de Lima Maria C.,Hantraye Philippe,Pereira de Almeida Luís,Déglon Nicole

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference41 articles.

1. Machado-Joseph disease.;L Sudarsky;Clin Neurosci,1995

2. Spinocerebellar ataxia type 3 phenotypically resembling parkinson disease in a black family.;K Gwinn-Hardy;Arch Neurol,2001

3. Dopamine transporter positron emission tomography in spinocerebellar ataxias type 1, 2, 3, and 6.;U Wullner;Arch Neurol,2005

4. Striatal and nigral pathology in a lentiviral rat model of Machado-Joseph disease.;S Alves;Hum Mol Genet,2008

5. Spinocerebellar ataxia type 1 and Machado-Joseph disease: incidence of CAG expansions among adult-onset ataxia patients from 311 families with dominant, recessive, or sporadic ataxia.;LP Ranum;Am J Hum Genet,1995

Cited by 133 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging therapies in hereditary ataxias;Trends in Molecular Medicine;2024-08

2. Hereditary Ataxias: From Bench to Clinic, Where Do We Stand?;Cells;2024-02-09

3. Drug repurposing of dopaminergic drugs to inhibit ataxin-3 aggregation;Biomedicine & Pharmacotherapy;2023-09

4. Decoding Neurodegeneration: A Comprehensive Review of Molecular Mechanisms, Genetic Influences, and Therapeutic Innovations;International Journal of Molecular Sciences;2023-08-21

5. RNA Interference Applications for Machado-Joseph Disease;RNA Therapeutics - History, Design, Manufacturing, and Applications;2023-05-24